BEXSERO (Meningococcal Group B Vaccine) is an FDA-approved vaccine to help protect against meningitis B. Learn more about meningitis B vaccination.
BEXSERO is the only MenB vaccine that combines 4 different antigenic components.5,6 Learn More Place an order today Stock up on BEXSERO with GSKDirect. Order Now Get the latest product updates Connect with a Sales Representative. Connect Now ...
BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approved for use in individuals aged 10 through 25 years.How do I counsel patients about meningitis B (MenB)? Our quick guide can help you get started. Be...
必思諾 B 型腦膜炎雙球菌疫苗 Bexsero Meningococcal Group B Vaccine 衛部菌疫輸字第 001150 號 產品說明 B 型腦膜炎雙球菌複合疫苗(重組吸附性) 配方與含量 注射用懸浮液 1 劑(0.5 毫升)含有: 重組 B 型奈瑟氏腦膜炎雙球菌 NHBA 融合蛋白 1,2,3 重組 B 型奈瑟氏腦膜炎雙球菌 NadA 蛋白 1,2,3 ...
Bexsero®: Targeting Meningococcal Group B Bexsero® (Meningococcal Group B Vaccine) is approved in the US for active immunization to help prevent invasive meningococcal disease caused by Neisseria meningitidis group B in adolescents and young adults from 10 years through 25 years of age1 ...
Shake the syringe immediately before use to form a homogeneous suspension. Do not use the vaccine if it cannot be resuspended.Parenteraldrug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not use if part...
Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered 90471: Immunization administration (includes percutaneous, intradermal, subcutaneous, or...
BEXSERO may not protect all vaccine recipients. BEXSERO may not provide protection against all meningococcal serogroup B strains [see Clinical Pharmacology (12.1)]. 5.4 Altered Immunocompetence Some individuals with altered immunocompetence may have reduced immune responses to BEXSERO. Complement Deficiency...
Invasive meningococcal disease (IMD), caused by Neisseria meningitidis (Nm) strains, is a life-threatening but vaccine-preventable condition. Bexsero is a four-component vaccine that offers broad protection against Nm of serogroup B (NmB), particularly common in Europe. In Switzerland, Bexsero has ...
The registry population includes pregnant women within the United States (US) who were immunized with the BEXSERO vaccine within 30 days prior to their last menstrual period (LMP) or at any time during pregnancy. The minimum criteria required for enrollment into the registry are as follows: ...